Skip to main content

Table 1 Demographic, clinical and echocardiographic characteristics.

From: Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides

POPULATION

OVERALL

n = 127

Group A

N = 74

Group B

N = 53

p-value

Age (years)

55.2 ± 6.8

54.5 ± 6.8

56.3 ± 6.8

0.155

Gender (M/F)

65/62

38/36

24/29

0.500

BMI (Kg/m2)

29.2 ± 5.0

29.1 ± 5.1

29.5 ± 5.2

0.867

Diabetes duration (years)*

3 (1-10)*

3 (1-10)*

3 (1-9)

0.954

Smokers

28 (22%)

14 (19%)

14 (26%)

0.577

Ex-smokers

40 (31%)

25 (34%)

15 (28%)

0.504

Hypertension

51 (40%)

27 (37%)

24 (45%)

0.361

Hypercholesterolemia

29 (23%)

19 (26%)

10 (19%)

0.447

Creatinine (mg/dl)

0.89 ± 0.21

0.87 ± 0.21

0.94 ± 0.21

0.115

Microalbuminuria

34 (29%)

18 (28%)

16 (31%)

0.666

LVEF (%)

59.4 ± 4.8

60.5 ± 5.5

58.8 ± 3.7

0.143

LVMI (g/m2.7)

43.7 ± 11.8

42.6 ± 12.1

45.2 ± 11.3

0.198

LVH

51 (40%)

27 (36%)

24 (45%)

0.361

  1. LVEF = left ventricular ejection fraction, LVMI = left ventricular mass index, LVH = left ventricular hypertrophy.
  2. *data are expressed as median and interquartile range